Juan Dubrot

4.1k total citations · 1 hit paper
45 papers, 2.1k citations indexed

About

Juan Dubrot is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Juan Dubrot has authored 45 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 15 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Juan Dubrot's work include Immune Cell Function and Interaction (23 papers), Immunotherapy and Immune Responses (21 papers) and T-cell and B-cell Immunology (19 papers). Juan Dubrot is often cited by papers focused on Immune Cell Function and Interaction (23 papers), Immunotherapy and Immune Responses (21 papers) and T-cell and B-cell Immunology (19 papers). Juan Dubrot collaborates with scholars based in Spain, Switzerland and United States. Juan Dubrot's co-authors include Ignacio Melero, Sandra Hervás‐Stubbs, Stéphanie Hugues, Asís Palazón, José Luis Perez‐Gracia, Walter Reith, Carlos Alfaro, Dale Brighouse, Fernanda V. Durães and Iván Martínez‐Forero and has published in prestigious journals such as Science, The Journal of Experimental Medicine and Immunity.

In The Last Decade

Juan Dubrot

44 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria–specific CD4 ⁺ T cells

2015 378 citations Matthew R. Hepworth, Thomas C. Fung et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juan Dubrot Spain	25	1.4k	841	525	276	156	45	2.1k
Ryoji Yagi United States	21	2.0k 1.5×	346 0.4×	584 1.1×	386 1.4×	113 0.7×	30	2.7k
Jonathan M. Coquet Sweden	23	2.5k 1.8×	531 0.6×	365 0.7×	163 0.6×	219 1.4×	43	3.1k
Norberto W. Zwirner Argentina	28	2.6k 1.9×	769 0.9×	919 1.8×	177 0.6×	336 2.2×	57	3.3k
Tatyana Chtanova Australia	21	2.0k 1.4×	518 0.6×	471 0.9×	95 0.3×	252 1.6×	36	2.8k
Lars Ohl Germany	13	3.0k 2.1×	864 1.0×	464 0.9×	143 0.5×	180 1.2×	17	3.5k
Soyoung Oh United States	17	1.5k 1.1×	759 0.9×	574 1.1×	179 0.6×	90 0.6×	20	2.2k
Rachel D. Kuns Australia	29	2.1k 1.5×	486 0.6×	440 0.8×	94 0.3×	211 1.4×	58	2.8k
Paul Rogers United States	19	2.2k 1.6×	571 0.7×	518 1.0×	109 0.4×	268 1.7×	29	2.8k
Alasdair R. Fraser United Kingdom	25	1.2k 0.9×	515 0.6×	617 1.2×	461 1.7×	107 0.7×	47	2.4k
Dagmar Breitfeld Germany	5	2.7k 2.0×	1.0k 1.2×	405 0.8×	106 0.4×	191 1.2×	7	3.3k

Countries citing papers authored by Juan Dubrot

Since Specialization

Citations

This map shows the geographic impact of Juan Dubrot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Dubrot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Dubrot more than expected).

Fields of papers citing papers by Juan Dubrot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Dubrot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Dubrot. The network helps show where Juan Dubrot may publish in the future.

Co-authorship network of co-authors of Juan Dubrot

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Dubrot. A scholar is included among the top collaborators of Juan Dubrot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Dubrot. Juan Dubrot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tost, Jörg, Daniele Campa, Alejandro Ibáñez‐Costa, et al.. (2025). Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. Seminars in Cancer Biology. 109. 101–124. 3 indexed citations

Lane-Reticker, Sarah Kate, Emily Kessler, Audrey J. Muscato, et al.. (2023). Protocol for in vivo CRISPR screening using selective CRISPR antigen removal lentiviral vectors. STAR Protocols. 4(1). 102082–102082. 2 indexed citations

Garnier, Laure, Juan Dubrot, Dale Brighouse, et al.. (2021). MHC Class II Antigen Presentation by Lymphatic Endothelial Cells in Tumors Promotes Intratumoral Regulatory T cell–Suppressive Functions. Cancer Immunology Research. 9(7). 748–764. 51 indexed citations

Dubrot, Juan, Amélie Sabine, Oliver Lyons, et al.. (2017). Cx47 fine-tunes the handling of serum lipids but is dispensable for lymphatic vascular function. PLoS ONE. 12(7). e0181476–e0181476. 19 indexed citations

Hepworth, Matthew R., Thomas C. Fung, Judith R. Kelsen, et al.. (2015). Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria–specific CD4 ⁺ T cells. Science. 348(6238). 1031–1035. 378 indexed citations breakdown →

Durães, Fernanda V., Jennifer Niven, Juan Dubrot, Stéphanie Hugues, & Monique Gannagé. (2015). Macroautophagy in Endogenous Processing of Self- and Pathogen-Derived Antigens for MHC Class II Presentation. Frontiers in Immunology. 6. 459–459. 25 indexed citations

Hammoudi, Pierre‐Mehdi, Damien Jacot, Christina Mueller, et al.. (2015). Fundamental Roles of the Golgi-Associated Toxoplasma Aspartyl Protease, ASP5, at the Host-Parasite Interface. PLoS Pathogens. 11(10). e1005211–e1005211. 90 indexed citations

Guéry, Leslie, Juan Dubrot, Dale Brighouse, et al.. (2014). Ag-Presenting CpG-Activated pDCs Prime Th17 Cells That Induce Tumor Regression. Cancer Research. 74(22). 6430–6440. 53 indexed citations

Melero, Ignacio, José I. Quetglas, Juan Dubrot, et al.. (2014). Strict Requirement for Vector-Induced Type I Interferon in Efficacious Antitumor Responses to Virally Encoded IL12. Cancer Research. 75(3). 497–507. 35 indexed citations

10.

Unzu, Carmen, Ignacio Melero, Aizea Morales‐Kastresana, et al.. (2014). Innate Functions of Immunoglobulin M Lessen Liver Gene Transfer with Helper-Dependent Adenovirus. PLoS ONE. 9(1). e85432–e85432. 7 indexed citations

11.

Quetglas, José I., Juan Dubrot, Jaione Bezunartea, et al.. (2012). Immunotherapeutic Synergy Between Anti-CD137 mAb and Intratumoral Administration of a Cytopathic Semliki Forest Virus Encoding IL-12. Molecular Therapy. 20(9). 1664–1675. 48 indexed citations

12.

Palazón, Asís, Álvaro Teijeira, Iván Martínez‐Forero, et al.. (2011). Agonist Anti-CD137 mAb Act on Tumor Endothelial Cells to Enhance Recruitment of Activated T Lymphocytes. Cancer Research. 71(3). 801–811. 112 indexed citations

13.

Alfaro, Carlos, Natalia Suárez, Iván Martínez‐Forero, et al.. (2011). Carcinoma-Derived Interleukin-8 Disorients Dendritic Cell Migration Without Impairing T-Cell Stimulation. PLoS ONE. 6(3). e17922–e17922. 34 indexed citations

14.

Dubrot, Juan, Asís Palazón, Carlos Alfaro, et al.. (2010). Intratumoral injection of interferon‐α and systemic delivery of agonist anti‐CD137 monoclonal antibodies synergize for immunotherapy. International Journal of Cancer. 128(1). 105–118. 37 indexed citations

15.

Fontanellas, Antonio, Sandra Hervás‐Stubbs, Itsaso Mauleón, et al.. (2010). Intensive Pharmacological Immunosuppression Allows for Repetitive Liver Gene Transfer With Recombinant Adenovirus in Nonhuman Primates. Molecular Therapy. 18(4). 754–765. 24 indexed citations

16.

Dubrot, Juan, Aitziber Portero, Gorka Orive, et al.. (2010). Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells. Cancer Immunology Immunotherapy. 59(11). 1621–1631. 32 indexed citations

17.

Dubrot, Juan, Carlos Alfaro, Asís Palazón, et al.. (2010). Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ. Cancer Immunology Immunotherapy. 59(8). 1223–1233. 82 indexed citations

18.

Arina, Ainhoa, Oihana Murillo, Juan Dubrot, et al.. (2008). Interleukin-15 liver gene transfer increases the number and function of IKDCs and NK cells. Gene Therapy. 15(7). 473–483. 19 indexed citations

19.

Melero, Ignacio, Oihana Murillo, Juan Dubrot, Sandra Hervás‐Stubbs, & José Luis Perez‐Gracia. (2008). Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies. Trends in Pharmacological Sciences. 29(8). 383–390. 83 indexed citations

20.

Arina, Ainhoa, Oihana Murillo, Juan Dubrot, et al.. (2007). Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer. Expert Opinion on Biological Therapy. 7(5). 599–615. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact